Kozak & Associates’s CyrusOne Inc Common Stock CONE Stock Holding History

Kozak & Associates’s Portfolio CONE Stock Details CONE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-915	Closed	-$83K	–	402
2022 Q1	$83K	Hold	915	–	–	0.05%	126
2021 Q4	$83K	Hold	915	–	–	0.05%	126
2021 Q3	$82K	Buy	+915	New	+$68.8K	0.05%	123

Kozak & Associates's CONE Position: Q2 2022 in Review

Kozak & Associates sold out of CyrusOne Inc Common Stock (CONE) in Q2 2022, closing a stake of 915 shares — an estimated $83K sold.

Kozak & Associates first reported a position in CONE in Q3 2021 and held it in 3 quarters. The position peaked at $83K in Q1 2022. 1 fund tracked by Wall St. Rank holds CONE as of Q2 2022.

Kozak & Associates reported no remaining CyrusOne Inc Common Stock position as of Q2 2022 after selling out during the quarter.
Kozak & Associates sold 915 CyrusOne Inc Common Stock shares in Q2 2022, an estimated $83K.
Kozak & Associates first reported a position in CyrusOne Inc Common Stock in Q3 2021 and held it in 3 quarters.
Kozak & Associates's CyrusOne Inc Common Stock position peaked at $83K in Q1 2022.
1 fund tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q2 2022.

Based on Kozak & Associates's 13F filing for Q2 2022, filed 12 Oct 2022.